ArriVent BioPharma, Inc. (NASDAQ:AVBP) is held by 119 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 4,401,083 | 295,048 | 7.19% | $101,532,985.00 |
| INFINITUM ASSET MANAGEMENT, LLC | 31 Mar, 2026 | 4,148,923 | 25,000 | 0.61% | $95,715,654.00 |
| HHLR ADVISORS, LTD. | 31 Mar, 2026 | 3,929,117 | 0 | 0.00% | $90,644,729.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 3,027,328 | 0 | 0.00% | $69,840,457.00 |
| FMR LLC | 31 Mar, 2026 | 3,016,132 | -687,440 | -18.56% | $69,582,163.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 2,530,301 | 157,463 | 6.64% | $58,374,044.00 |
| Octagon Capital Advisors LP | 31 Mar, 2026 | 1,971,054 | 0 | 0.00% | $45,472,216.00 |
| Novo Holdings A/S | 31 Mar, 2026 | 1,942,142 | 0 | 0.00% | $44,805,216.00 |
| Sofinnova Investments, Inc. | 31 Mar, 2026 | 1,696,752 | 0 | 0.00% | $39,144,069.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,528,893 | 1,528,893 | 0.00% | $35,271,562.00 |
| General Catalyst Group Management, LLC | 31 Mar, 2026 | 1,494,786 | 0 | 0.00% | $34,484,713.00 |
| State Street Corp | 31 Mar, 2026 | 1,421,415 | 329,435 | 30.17% | $32,792,044.00 |
| Vivo Capital, LLC | 31 Mar, 2026 | 885,916 | 885,916 | 0.00% | $20,438,082.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 853,427 | -631,625 | -42.53% | $19,688,560.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 803,652 | 50,133 | 6.65% | $18,544,348.00 |
| Point72 Asset Management, L.P. | 31 Mar, 2026 | 748,195 | 531,535 | 245.33% | $17,260,859.00 |
| HSG Holding Ltd | 31 Mar, 2026 | 663,308 | 0 | 0.00% | $13,982,533.00 |
| Fund 1 Investments, LLC | 31 Mar, 2026 | 499,990 | 499,990 | 0.00% | $11,534,769.00 |
| UBS Group AG | 31 Mar, 2026 | 486,263 | 35,343 | 7.84% | $11,218,087.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Mar, 2026 | 426,281 | 383,251 | 890.66% | $9,834,303.00 |